Class Action Lawsuits
|
Zyprexa® is an anti-psychotic medication that was approved in 1996 by the U.S. Food and Drug Administration (FDA) for the treatment of schizophrenia. Zyprexa® is a member of a class of drugs commonly referred to as "second generation anti-psychotics" ("SGAs") or "atypical anti-psychotics." When Zyprexa® was approved in 1996, there were 2 other such SGA medications already available on the market. Consequently, Zyprexa® is considered a "me-too" drug, joining a class of existing medications prescribed for the treatment of common disorders.
|
Class Action Lawsuits